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In July of 2019, the Maine Naloxone Distribution Initiative (MNDI) launched an overdose education, 
prevention, and naloxone distribution project. Public health and harm reduction partners, known as Tier 1 
Distributors, began distributing state-supplied naloxone rescue kits across Maine to clinicians, community 
partners, and end users. This brief provides information on naloxone distribution and reported overdose 
reversals by the Tier 1 organizations comprising the MNDI from the initiation of the project through 
March 2021, with a particular emphasis on the first quarter of 2021. 
Tier 1 organizations include Bangor Public 
Health (BPH), Portland Public Health (PPH), 
MaineGeneral Health (MG), and Maine Access 
Points (MAP). BPH serves the Aroostook, 
Downeast, and Penquis public health districts, 
PPH serves Cumberland and York, and MG 
serves Central, Midcoast, and Western. MAP 
distributes naloxone statewide with a particular 
focus on rural regions. Data from the Office of 
the Attorney General’s (OAG) law enforcement 
administered naloxone program have also 
been included to provide an overview of the 
combined public health, harm reduction, and 
public safety efforts in Maine.
Fatal drug overdoses increased in 2020 and that 
trend has continued in the first quarter of 2021. 
Currently, there is no comprehensive way to 
fully enumerate the total of nonfatal overdoses 
as this metric relies on voluntary reporting. 
Thus, it is difficult to quantify the full efficacy 
of naloxone distribution efforts during this 
troubling period. The distribution and reported 
reversal data tables and figure in this report offer 
conservative estimates of the lives saved through 
public health, harm reduction, and safety efforts, 
which prevented the number of drug deaths 
from potentially being much higher. 
Additional resources, data, and visualizations are 
available at the Maine Drug Data Hub: https://mainedrugdata.org/.
Figure 1: Number of naloxone doses distributed by the 
Maine Naloxone Distribution Initiative from January 
through March 2021 
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Public Health—Tier 1 Distributors
During the first quarter of 2021 (January–March): 
• 16,236 doses of naloxone have been distributed 
• 383 overdose reversals have been voluntarily reported. 
From July 2019 through March 2021 (MNDI project-to-date totals):
• 76,562  doses of naloxone have been distributed
• 1692 overdose reversals have been voluntarily reported.
Public Safety—Law Enforcement Agencies
During the first quarter of 2021 (January–March): 
• 2004 doses of naloxone have been distributed 
• 50 overdose reversals have been voluntarily reported. 
From July 2019 through March 2021: 
• 7952 doses of naloxone have been distributed
• 371 overdose reversals have been voluntarily reported.








BPH 1768 10,550 732 224 516 13,790
PPH 3792 8640 96 292 1704 14,524
MG 2550 5870 2032 784 1622 12,858
MAP (IM) 3486 19,561 2216 2834 1888 29,985
MAP (IN) 510 3599 410 392 494 5405
OAG 2034 3914 852 288 864 7952
TOTAL 14,140 52,134 6338 4814 7088 84,514
1 2019 data is for July through December only.
Table 2  Number of overdose reversals1 voluntarily reported to Tier 1 distributors (by individuals  








BPH 17 289 49 55 93 503
PPH 28 304 4 - 10 346
MG 1 87 10 7 15 120
MAP 29 521 64 38 38 690
OAG 50 271 26 10 14 371
OD-ME app3 - 31 0 0 2 33
TOTAL 125 1503 153 110 172 2063
1 Reversal totals are conservative estimates as not all reversals are reported. 
2 2019 data is July through December only.
3 OD-ME app is a mobile phone app developed in 2020 to support naloxone administration.
